Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases

Chemokines, and their receptors play a crucial role in the pathophysiology of cardiovascular diseases (CVD). Chemokines classically mediate their effects by binding to G-protein-coupled receptors. The discovery that chemokines can also bind to atypical chemokine receptors (ACKRs) and initiate altern...

Full description

Bibliographic Details
Main Authors: Vincent Duval, Paul Alayrac, Jean-Sébastien Silvestre, Angélique Levoye
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.906586/full
_version_ 1811332773603966976
author Vincent Duval
Paul Alayrac
Jean-Sébastien Silvestre
Angélique Levoye
Angélique Levoye
author_facet Vincent Duval
Paul Alayrac
Jean-Sébastien Silvestre
Angélique Levoye
Angélique Levoye
author_sort Vincent Duval
collection DOAJ
description Chemokines, and their receptors play a crucial role in the pathophysiology of cardiovascular diseases (CVD). Chemokines classically mediate their effects by binding to G-protein-coupled receptors. The discovery that chemokines can also bind to atypical chemokine receptors (ACKRs) and initiate alternative signaling pathways has changed the paradigm regarding chemokine-related functions. Among these ACKRs, several studies have highlighted the exclusive role of ACKR3, previously known as C-X-C chemokine receptor type 7 (CXCR7), in CVD. Indeed, ACKR3 exert atheroprotective, cardioprotective and anti-thrombotic effects through a wide range of cells including endothelial cells, platelets, inflammatory cells, fibroblasts, vascular smooth muscle cells and cardiomyocytes. ACKR3 functions as a scavenger receptor notably for the pleiotropic chemokine CXCL12, but also as a activator of different pathways such as β-arrestin-mediated signaling or modulator of CXCR4 signaling through the formation of ACKR3-CXCR4 heterodimers. Hence, a better understanding of the precise roles of ACKR3 may pave the way towards the development of novel and improved therapeutic strategies for CVD. Here, we summarize the structural determinant characteristic of ACKR3, the molecules targeting this receptor and signaling pathways modulated by ACKR3. Finally, we present and discuss recent findings regarding the role of ACKR3 in CVD.
first_indexed 2024-04-13T16:42:02Z
format Article
id doaj.art-7ea10500dcaf4f0b8f8f1132b06092a8
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-13T16:42:02Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-7ea10500dcaf4f0b8f8f1132b06092a82022-12-22T02:39:12ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-06-011310.3389/fendo.2022.906586906586Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular DiseasesVincent Duval0Paul Alayrac1Jean-Sébastien Silvestre2Angélique Levoye3Angélique Levoye4Université Paris Cité, Institut National de la Santé Et Recherche Médicale (INSERM), Paris Cardiovascular Research Center PARCC, Paris, FranceUniversité Paris Cité, Institut National de la Santé Et Recherche Médicale (INSERM), Paris Cardiovascular Research Center PARCC, Paris, FranceUniversité Paris Cité, Institut National de la Santé Et Recherche Médicale (INSERM), Paris Cardiovascular Research Center PARCC, Paris, FranceUniversité Paris Cité, Institut National de la Santé Et Recherche Médicale (INSERM), Paris Cardiovascular Research Center PARCC, Paris, FranceUFR Santé Médecine Biologie Humaine, Université Sorbonne Paris Nord, Bobigny, FranceChemokines, and their receptors play a crucial role in the pathophysiology of cardiovascular diseases (CVD). Chemokines classically mediate their effects by binding to G-protein-coupled receptors. The discovery that chemokines can also bind to atypical chemokine receptors (ACKRs) and initiate alternative signaling pathways has changed the paradigm regarding chemokine-related functions. Among these ACKRs, several studies have highlighted the exclusive role of ACKR3, previously known as C-X-C chemokine receptor type 7 (CXCR7), in CVD. Indeed, ACKR3 exert atheroprotective, cardioprotective and anti-thrombotic effects through a wide range of cells including endothelial cells, platelets, inflammatory cells, fibroblasts, vascular smooth muscle cells and cardiomyocytes. ACKR3 functions as a scavenger receptor notably for the pleiotropic chemokine CXCL12, but also as a activator of different pathways such as β-arrestin-mediated signaling or modulator of CXCR4 signaling through the formation of ACKR3-CXCR4 heterodimers. Hence, a better understanding of the precise roles of ACKR3 may pave the way towards the development of novel and improved therapeutic strategies for CVD. Here, we summarize the structural determinant characteristic of ACKR3, the molecules targeting this receptor and signaling pathways modulated by ACKR3. Finally, we present and discuss recent findings regarding the role of ACKR3 in CVD.https://www.frontiersin.org/articles/10.3389/fendo.2022.906586/fullatypical chemokine receptorsACKR3chemokinecardiovascular diseasessignalling
spellingShingle Vincent Duval
Paul Alayrac
Jean-Sébastien Silvestre
Angélique Levoye
Angélique Levoye
Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases
Frontiers in Endocrinology
atypical chemokine receptors
ACKR3
chemokine
cardiovascular diseases
signalling
title Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases
title_full Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases
title_fullStr Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases
title_full_unstemmed Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases
title_short Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases
title_sort emerging roles of the atypical chemokine receptor 3 ackr3 in cardiovascular diseases
topic atypical chemokine receptors
ACKR3
chemokine
cardiovascular diseases
signalling
url https://www.frontiersin.org/articles/10.3389/fendo.2022.906586/full
work_keys_str_mv AT vincentduval emergingrolesoftheatypicalchemokinereceptor3ackr3incardiovasculardiseases
AT paulalayrac emergingrolesoftheatypicalchemokinereceptor3ackr3incardiovasculardiseases
AT jeansebastiensilvestre emergingrolesoftheatypicalchemokinereceptor3ackr3incardiovasculardiseases
AT angeliquelevoye emergingrolesoftheatypicalchemokinereceptor3ackr3incardiovasculardiseases
AT angeliquelevoye emergingrolesoftheatypicalchemokinereceptor3ackr3incardiovasculardiseases